NeuroPace Total Liabilities and Share Holders Equity 2020-2024 | NPCE

NeuroPace total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

NeuroPace Total Liabilities and Share Holders Equity 2020-2024 | NPCE

NeuroPace total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$209.2B
Intuitive Surgical (ISRG)$190.8B
Alcon (ALC)$45.5B
IQVIA Holdings (IQV)$39.4B
Edwards Lifesciences (EW)$39.3B
IDEXX Laboratories (IDXX)$35.8B
DexCom (DXCM)$27.5B
Waters (WAT)$22.6B
SONOVA HOLDING (SONVY)$22.1B
STERIS (STE)$21.9B
Hologic (HOLX)$18.4B
Sysmex ADR (SSMXY)$12.9B
Fresenius Medical Care AG KGaA (FMS)$12.6B
Globus Medical (GMED)$11.1B
Penumbra (PEN)$9.3B
Teleflex (TFX)$9.2B
Masimo (MASI)$8.7B
Glaukos (GKOS)$7.9B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.7B
Inari Medical (NARI)$3.1B
Veracyte (VCYT)$3B
TransMedics (TMDX)$3B
LivaNova (LIVN)$2.8B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$2B
RxSight (RXST)$1.9B
Alphatec Holdings (ATEC)$1.4B